Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum NeutriSci International Inc V.NU.H

Alternate Symbol(s):  NRXCF

NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the production, and formulation of nutraceutical products within the business-to-business (B2B) industry. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans... see more

TSXV:NU.H - Post Discussion

View:
Post by lscfa on May 28, 2022 4:22pm

Q1 on sedar

As usual incompetent explanations.

 

 

Revenue

Gross profit

Q1 22

173,331

(2,654)

Q4 21

25,874

(21,787)

Q3 21

-

 

Q2 21

55,020

1,240

Q1 21

-

 

 

 

Sales revenue, for the three months ended March 31, 2022 were $173,331, as compared to $nil for the three months ended March 31, 2021. This increase related primarily to a large shipment of the Company’s Tabletz product to Japan.
 
Cost of sales for the three months ended March 31, 2022 was $175,985, as compared to $nil for the three months ended March 31, 2021. The increase in cost of sales is consistent with the increase to revenue.

Comment by Edcando on May 28, 2022 6:16pm
One more point to add. I'm 99.9999% sure that the high cost of goods includes some (if not all) of the cost of goods for this last tranche . As per the explanation I was given for why the first tranche couldn't go on Q4. Whether it's Glen or next fins that confirms this  (one way or the other ), I'd imagine most of our profit is in the last tranche. 
Comment by navajojoe on May 29, 2022 9:18am
This post has been removed in accordance with Community Policy
Comment by richkat on May 29, 2022 12:23pm
Hey navajojoe just noticed that you sure like to insult people on  many forums.  Fun guy to be around.
Comment by Edcando on May 29, 2022 12:58pm
Bwahahahaha, he's here now?! He's the biggest clown on SH. Delusional with multiple confirmed aliases where he speaks to himself. Sends abusive PMs. A big know nothing. He's not just the joke. He's the punchline too ! Lol
Comment by Edcando on May 29, 2022 1:00pm
I have him and many of his other confirmed aliases on block . He's had other ones deleted from SH by them. The filunniest is he's only posting here because I constantly call him out on another board. Except he pretends to have me blocked so how would we know I posted here to reply.? Such a loser 
Comment by navajojoe on May 29, 2022 9:07pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities